Is a complete AIM/IXI research report available?

No complete published report is available for aim/IXI (AIM/IXI) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

AIM/IXI (AIM/IXI)

London Stock Exchange AIM: AIM/IXI · GBX

GBX 8.00

+0.50 (+6.7%)· Recorded snapshot

Market cap	16.4M
Revenue (ttm)	7.3M
Net income (ttm)	-1.8M
EPS (ttm)	-GBX 0.02
Shares out	218M
Volume	10,741
Beta	0.11

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 7.3M
Net income (ttm): -1.8M
EPS (ttm): -GBX 0.02
Market cap: 16.4M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

All AIM/IXI indicators

Market & fundamental data

Available fields

185

Groups with data

Currency

GBP

Showing 185 of 185 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	79
Employees Change	-2%
Employees Change Percent	-2.47
Enterprise value	GBX 15.2M
Exchange	London Stock Exchange AIM
Financial currency	GBP
First seen	2026-05-10
Industry	Biotechnology
Isin	GB00BFXR4C20
Last refreshed	2026-09-11
Market cap	GBX 16.4M
Price	GBX 8
Price currency	GBX
Rev Per Employee	92,088.61x
Sector	Healthcare
Sector PE	20.62
Sector PE Fwd	13.37
Sic	2833
Symbol	aim/IXI
Website	https://ixico.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-11.11%
EV/Sales	2.09x
FCF yield	-14.03%
P/B ratio	1.53x
P/S ratio	2.25x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-39.4%
EBITDA Margin	-36.67%
Gross margin	50.76%
Gross Profit	GBX 3.7M
Gross Profit Growth	12.56%
Gross Profit Growth Q	32.08%
Gross Profit Growth3 Y	-5.48%
Gross Profit Growth5 Y	-11.07%
Net Income	GBX -1.8M
Net Income Growth Years	1%
Pretax Margin	-43.27%
Profit Margin	-24.98%
Profit Per Employee	GBX -23,000
ROA	-13.24
Roa5y	-4.23
ROCE	-25.63
ROE	-15.8
Roe5y	-4.26
ROIC	-29.85

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-11.78%
Cagr1y	-32.51%
Cagr3y	-26.31%
Cagr5y	-37.02%
EPS Growth Years	1
Revenue Growth	13.04x
Revenue Growth Q	23.1x
Revenue Growth Qo Q	18.73x
Revenue Growth Quarters	3x
Revenue Growth Years	1x
Revenue Growth3 Y	-2.81x
Revenue Growth5 Y	-5.96x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 0.54
Assets	GBX 13M
Cash	GBX 1.7M
Current Assets	GBX 5.1M
Current Liabilities	GBX 1.8M
Debt	GBX 559,000
Debt Equity	GBX 0.05
Debt FCF	GBX -0.24
Equity	GBX 10.7M
Interest Coverage	-136.5
Liabilities	GBX 2.3M
Long Term Assets	GBX 7.9M
Long Term Liabilities	GBX 467,000
Net Cash	GBX 1.1M
Net Cash By Market Cap	GBX 6.82
Net Cash Growth	-76.43%
Net Debt Equity	GBX -0.1
Tangible Book Value	GBX 3.7M
Tangible Book Value Per Share	GBX 0.04
WACC	4.77

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.83
Net Working Capital	GBX 1.7M
Quick ratio	2.83
Working Capital	GBX 3.3M
Working Capital Turnover	GBX 1.64

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-37.83%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-71.43%
1Y total return	-32.49%
200-day SMA	8.83
3Y total return	-60%
50-day SMA	8.02
50-day SMA vs 200-day SMA	50under200
5Y total return	-90.09%
All Time High	145
All Time High Change	-94.48%
All Time High Date	2013-12-09
All Time Low	6.26
All Time Low Change	27.8%
All Time Low Date	2026-05-13
ATR	0.62
Beta	0.11
Beta1y	-0.35
Beta2y	-0.06
Ch YTD	-31.91
High	8
High52	15
High52 Date	2025-09-30
High52ch	-46.67%
Low	7.18
Low52	6.26
Low52 Date	2026-05-13
Low52ch	27.8%
Ma50ch	-0.24%
Price vs 200-day SMA	-9.44%
RSI	34.04
RSI Monthly	38.17
RSI Weekly	39.9
Sharpe ratio	-0.78x
Sharpe Ratio3y	-0.38x
Sharpe Ratio5y	-0.75x
Sortino ratio	-1.08
Sortino Ratio3y	-0.49
Sortino Ratio5y	-1.03
Total Return	-37.83%
Tr YTD	-31.91
Tr1w	6.67%
Tr3m	-7.51%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	95,379,262%
Net Borrowing	-202,000
Shares Insiders	1.12%
Shares Institutions	41.46%
Shares Out	218,047,596
Shares Qo Q	-0.04%
Shares Yo Y	37.83%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX -2.5M
Adjusted OCF	-2,387,000
Average Volume	20,173.45x
Bv Per Share	0.12
CAPEX	GBX -150,000
Ch10y	-71.43
Ch1w	6.67
Ch1y	-32.49
Ch3m	-7.51
Ch3y	-60
Ch5y	-90.09
Ch6m	2.56
Change	6.67%
Change From Open	11.42
Close	7.5
Days Gap	-4.27
Depreciation Amortization	198,000
Dollar Volume	85,928
Earnings Date	2026-12-04
EBIT	GBX -2.9M
EBITDA	GBX -2.7M
EPS	GBX -0.02
F Score	1
FCF	GBX -2.3M
FCF EV Yield	-15.06x
FCF Per Share	GBX -0.01
Financing CF	-202,000
Fiscal Year End	September
Founded	1,995
Income Tax	GBX -1.3M
Investing CF	-988,000
Is Primary Listing	1
Last Earnings Date	2026-05-19
Last Report Date	2026-03-31
Ma150	7.99
Ma150ch	0.11%
Ma20	7.56
Ma20ch	5.78%
Net CF	-3,335,000
Next Earnings Date	2026-12-04
Open	7.18
Position In Range	100
Ppne	584,000
Price Date	2026-09-10
Ptbv Ratio	4.43
Relative Volume	0.53x
Revenue	7,275,000x
SBC By Revenue	3.33x
Share Based Comp	242,000
Tax By Revenue	-18.3x
Tr6m	2.56%
Volume	10,741
Z Score	1.47

AIM/IXI (AIM/IXI)

Price

Financial snapshot

Fair-value bridge

Latest news · AIM/IXI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AIM/IXI indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on AIM/IXI

Frequently asked questions